Rapid microfluidic isolation of virally infected primary bronchial epithelial cells for single-cell RNA sequencing.

Autor: Kimbley LM; Cancer Sciences, Faculty of Medicine, University of Southampton, Southampton, SO16 6YD, UK., Parker R; Cancer Sciences, Faculty of Medicine, University of Southampton, Southampton, SO16 6YD, UK., Jongen MS; Centre for Hybrid Biodevices, Institute of Life Sciences, University of Southampton, Southampton, SO17 1BJ, UK.; Human Development & Health, Faculty of Medicine, University of Southampton, Southampton, SO16 6YD, UK., Holloway JW; Human Development & Health, Faculty of Medicine, University of Southampton, Southampton, SO16 6YD, UK., Swindle EJ; Clinical & Experimental Sciences, Faculty of Medicine, University of Southampton, Southampton, SO16 6YD, UK., Rose-Zerilli MJ; Cancer Sciences, Faculty of Medicine, University of Southampton, Southampton, SO16 6YD, UK.

Publikováno v: BioTechniques [Biotechniques] 2021 Jul 16. Date of Electronic Publication: 2021 Jul 16.

BIRC-3 mutated monoclonal B lymphocytosis without evolution to chronic lymphocytic leukemia (CLL).

Autor: Nasr, Amen Allah^1,2,3 (AUTHOR), Fund, Xavier^3,4 (AUTHOR), Barreau, Sylvain^1,3 (AUTHOR), Desterke, Christophe^2,3 (AUTHOR), Borie, Claire^3,4 (AUTHOR), Oudrhiri, Noufissa^1,3,4 (AUTHOR), Faivre, Jamila⁴ (AUTHOR), Bennaceur-Griscelli, A.^1,2,3,4,5 (AUTHOR), Turhan, A. G.^1,2,3,4,5,6 (AUTHOR) turviv33@gmail.com

Publikováno v: Leukemia & Lymphoma. May2024, Vol. 65 Issue 5, p692-695. 4p.

Comparison of genomic alterations in Epstein–Barr virus‐positive and Epstein–Barr virus‐negative diffuse large B‐cell lymphoma.

Autor: Liu, Fang¹ (AUTHOR) gyliufang@hotmail.com, Tian, Sufang² (AUTHOR), Liu, Qing¹ (AUTHOR), Deng, Yuanfei¹ (AUTHOR), He, Qingyan¹ (AUTHOR), Shi, Qianyun³ (AUTHOR), Chen, Gang⁴ (AUTHOR), Xu, Xiuli⁵ (AUTHOR), Yuan, Jiayin¹ (AUTHOR), Nakamura, Shigeo⁶ (AUTHOR), Karube, Kennosuke⁶ (AUTHOR), Wang, Zhe⁵ (AUTHOR) zhwang@fmmu.edu.cn

Publikováno v: Cancer Medicine. Feb2024, Vol. 13 Issue 4, p1-16. 16p.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Genomic disruption of the histone methyltransferase SETD2 in chronic lymphocytic leukaemia.

Autor: Parker H; Academic Unit of Cancer Sciences, Faculty of Medicine, Cancer Research UK Centre and Experimental Cancer Medicine Centre, University of Southampton, Southampton, UK., Rose-Zerilli MJ; Academic Unit of Cancer Sciences, Faculty of Medicine, Cancer Research UK Centre and Experimental Cancer Medicine Centre, University of Southampton, Southampton, UK., Larrayoz M; Academic Unit of Cancer Sciences, Faculty of Medicine, Cancer Research UK Centre and Experimental Cancer Medicine Centre, University of Southampton, Southampton, UK., Clifford R; Oxford National Institute for Health Research, Biomedical Research Centre/Molecular Diagnostic Centre, University of Oxford, Oxford, UK., Edelmann J; Department of Internal Medicine III, Ulm University, Ulm, Germany., Blakemore S; Academic Unit of Cancer Sciences, Faculty of Medicine, Cancer Research UK Centre and Experimental Cancer Medicine Centre, University of Southampton, Southampton, UK., Gibson J; Centre for Biological Sciences, Faculty of Natural and Environmental Sciences, University of Southampton, Southampton, UK., Wang J; Centre for Molecular Oncology, Barts Cancer Institute, Queen Mary's, University of London, London, UK., Ljungström V; Department of Immunology, Genetics and Pathology, Science for Life Laboratory, Uppsala University, Uppsala, Sweden., Wojdacz TK; Academic Unit of Cancer Sciences, Faculty of Medicine, Cancer Research UK Centre and Experimental Cancer Medicine Centre, University of Southampton, Southampton, UK., Chaplin T; Centre for Molecular Oncology, Barts Cancer Institute, Queen Mary's, University of London, London, UK., Roghanian A; Academic Unit of Cancer Sciences, Faculty of Medicine, Cancer Research UK Centre and Experimental Cancer Medicine Centre, University of Southampton, Southampton, UK., Davis Z; Department of Molecular Pathology, Royal Bournemouth Hospital, Bournemouth, UK., Parker A; Department of Molecular Pathology, Royal Bournemouth Hospital, Bournemouth, UK., Tausch E; Department of Internal Medicine III, Ulm University, Ulm, Germany., Ntoufa S; Institute of Applied Biosciences, Center for Research and Technology Hellas, Thessaloniki, Greece., Ramos S; Oxford National Institute for Health Research, Biomedical Research Centre/Molecular Diagnostic Centre, University of Oxford, Oxford, UK., Robbe P; Oxford National Institute for Health Research, Biomedical Research Centre/Molecular Diagnostic Centre, University of Oxford, Oxford, UK., Alsolami R; Oxford National Institute for Health Research, Biomedical Research Centre/Molecular Diagnostic Centre, University of Oxford, Oxford, UK., Steele AJ; Academic Unit of Cancer Sciences, Faculty of Medicine, Cancer Research UK Centre and Experimental Cancer Medicine Centre, University of Southampton, Southampton, UK., Packham G; Academic Unit of Cancer Sciences, Faculty of Medicine, Cancer Research UK Centre and Experimental Cancer Medicine Centre, University of Southampton, Southampton, UK., Rodríguez-Vicente AE; Department of Haematology, University Hospital of Salamanca-Biomedical Research Institute of Salamanca, IBMCC, Comprehensive Cancer Center Research, University of Salamanca-CSIC, Salamanca, Spain., Brown L; Academic Unit of Cancer Sciences, Faculty of Medicine, Cancer Research UK Centre and Experimental Cancer Medicine Centre, University of Southampton, Southampton, UK., McNicholl F; Department of Haematology, Altnagelvin Area Hospital, Western Health and Social Care Trust, Londonderry, UK., Forconi F; Academic Unit of Cancer Sciences, Faculty of Medicine, Cancer Research UK Centre and Experimental Cancer Medicine Centre, University of Southampton, Southampton, UK., Pettitt A; Department of Molecular and Clinical Cancer Medicine, Royal Liverpool and Broadgreen University Hospitals NHS Trust, Liverpool, UK., Hillmen P; Department of Haematology, St James's University Hospital, Leeds, UK., Dyer M; College of Medicine, Biological Sciences and Psychology, University of Leicester, Leicester, UK., Cragg MS; Academic Unit of Cancer Sciences, Faculty of Medicine, Cancer Research UK Centre and Experimental Cancer Medicine Centre, University of Southampton, Southampton, UK., Chelala C; Centre for Molecular Oncology, Barts Cancer Institute, Queen Mary's, University of London, London, UK., Oakes CC; Division of Hematology, Department of Internal Medicine, The Ohio State University, Columbus, OH, USA., Rosenquist R; Department of Immunology, Genetics and Pathology, Science for Life Laboratory, Uppsala University, Uppsala, Sweden., Stamatopoulos K; Institute of Applied Biosciences, Center for Research and Technology Hellas, Thessaloniki, Greece., Stilgenbauer S; Department of Internal Medicine III, Ulm University, Ulm, Germany., Knight S; Oxford National Institute for Health Research, Biomedical Research Centre/Molecular Diagnostic Centre, University of Oxford, Oxford, UK., Schuh A; Oxford National Institute for Health Research, Biomedical Research Centre/Molecular Diagnostic Centre, University of Oxford, Oxford, UK., Oscier DG; Academic Unit of Cancer Sciences, Faculty of Medicine, Cancer Research UK Centre and Experimental Cancer Medicine Centre, University of Southampton, Southampton, UK.; Department of Molecular Pathology, Royal Bournemouth Hospital, Bournemouth, UK., Strefford JC; Academic Unit of Cancer Sciences, Faculty of Medicine, Cancer Research UK Centre and Experimental Cancer Medicine Centre, University of Southampton, Southampton, UK.

Publikováno v: Leukemia [Leukemia] 2016 Nov; Vol. 30 (11), pp. 2179-2186. Date of Electronic Publication: 2016 May 20.